About Revolutions Medical Product - RMCP
Revolution Medical's products include the Rev Vac safety syringe, safety blood drawing device and safety IV catheter. The world market for safety-engineered medical devices (SEMDs) is projected to exceed 2 billion this year and is forecasted to maintain a 20% annual growth rate in the near term. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion. The Rev Vac safety syringe and the Rev ColorMRI have not yet been cleared by the FDA for sale in the United States.
Since inception, the Company’s principal business has been to complete the development of and to commercialize color MRI Technology. The technology consists of software, which uses various color masks to produce full-color composite images from gray-scale MRI output. The resulting color images can be quickly viewed individually or all together as a “riffle stack”.
A riffle stack consists of the individual MRI images assembled to create a single composite image that contains the data from the individual images. The riffle stack allows a radiologist, using a computer mouse, to page through the images, creating a 3-D appreciation of the colorized MRI output even though the images themselves are not 3-D.
The software program can also segment the data and create a true 3-D image of the area to be examined. For instance, bone, fluid and other tissue displayed in an MRI scan of the head can be electronically eliminated to allow a 3-D rendering of just the brain.
The color images can be transferred to a CD-ROM or other digital storage device, instead of bulky film, for storage or for a patient to take to their referring physician. Because the color images are transferred to digital storage in a standard *.jpeg format, the color images can be viewed on any PC without the need for special software. The Rev ColorMRI has not yet been cleared by the FDA for sale in the United States.
Color MRI Video: http://www.revolutionsmedical.com/RevMed-ColorMRI-Video.php
Rev Vac Safety Syringe
The Rev Vac Safety Syringe and Phlebotomy (blood drawing) Device operate the same as a standard syringe and device. No additional training, skills, or procedures are necessary. The both products work on a vacuum principle, where pressing the plunger in them creates a vacuum. When the plunger reaches the bottom, the needle is captured. A further push on the plunger breaks the seal, and the needle retracts into the plunger barrel. The vacuum is maintained, so the needle cannot be removed from the plunger.
Revolutions Medical owns the patents and will manufacture a disposable retractable syringe and phlebotomy device. The products use a proprietary patented technology in which a vacuum causes the needle to retract into the barrel of the syringe or device after an injection is administered or blood is drawn. Prototype units have been produced and tested, but no units have been manufactured. The products have been designed to be manufactured at a cost that is approximately equal to the cost of traditional disposable syringes and phlebotomy devices and are intended to be a safe replacement for existing non-safe syringes and phlebotomy devices and even currently marketed syringes and devices labeled as safety products.
With traditional syringes and phlebotomy devices, a needle contaminated with a patient’s blood remains a danger to healthcare professionals handling the needle until it is permanently disposed of in a proper biohazard containment unit. Revolutions Medical’s safety products do not present a “needlestick” hazard to health professionals after use because the contaminated needle is retracted into the barrel of the safety product and locked in place. The Rev Vac safety syringe has not yet been cleared by the FDA for sale in the United States.
Safety Syringe Video: http://www.revolutionsmedical.com/RevMed-RevVacSafetySyringe.php
Rondald Wheet - CEO, Chairman of the Board
Mr. Wheet has over fifteen (15) years experience in the investment banking industry and while working for several NASD registered broker dealers has raised in excess of $100 million for small cap companies. He held five licenses with the NASD; series 4, 7, 24, 63, and 65. He operated in a management and principal capacity for 10 years during that time and was a compliance officer for 2 years. He worked for investment firms such as Cohig & Associates, Scott and Stringfellow, Fortress Financial, and RichMark Capital. He was in charge of opening up three different brokerage offices from the beginning, including finding ideal office space, hiring personnel, becoming NASD compliant and turning them into successful branch offices. He started his own consulting business in 2002, Mansfield Garrett, Inc., and worked with many start up and micro cap companies; giving advice on capital raising, strategic partnerships, stock awareness, hiring top management and going to the public market. He served on the Board of Directors for Clear Image, Inc. since 2004. Ron is past President of the Metropolitan Exchange Club of Charleston, SC. He received a Bachelor of Science degree from the University of Towson in both Finance and International Business in 1987.
Thomas O’Brien - President
Mr. O’Brien has more than twenty (20) years of general management experience in the medical device industry. He has special expertise in domestic and international sales, marketing and distribution of high technology medical systems and services. He has held executive positions with medical industry leaders such as Pfizer, Toshiba, and Johnson and Johnson owned Technicare Corporation. In 1995 he joined Spectrum Technology, a cosmetic laser company, as Vice President of Sales and Marketing. Spectrum was acquired by Palomar Corporation in 1996, and Mr. O’Brien went on to become Executive President for all of the Palomar companies. In 1996/1997 he became the President and CEO of Cosmetic Technology International, a cosmetic laser center business operating worldwide. He has most recently been the President and CEO of BioTrack, Inc. which has developed a device for the localization of breast cancer. He has also been CEO of Medical Online, Inc., an online internet medical consulting company. He has received a B.S. in foreign languages from the University of Maryland, served in the U.S. Air Force Security Service and also at the National Security Agency as a Chinese linguist.
Finalcials Dec 4th, 2008
Revolutions Medical Filed for Patent Protection in Europe for its Pending MRI PatentsBusiness Wire(Wed 10:08am)
REVOLUTIONS MEDICAL CORP FinancialsEDGAR Online Financials(Thu, Dec 4)
Revolutions Medical Completes Merger with Clear ImageBusiness Wire(Tue, Dec 2)
REVOLUTIONS MEDICAL CORP Files SEC form 8-K, Other EventsEDGAR Online(Mon, Dec 1)
Revolutions Medical Patent NewsBusiness Wire(Thu, Nov 20)
Revolutions Medical Corporation Files Pre Market 510K Application with the FDA for 3cc Rev Vac Safety SyringeBusiness Wire(Tue, Oct 28)
REVOLUTIONS MEDICAL CORP FinancialsEDGAR Online Financials(Thu, Sep 11)
Revolutions Medical Signs Contract for Rev Vac Manufacturing Service with Strategic Product Development, Inc.Business Wire(Thu, Sep 11)
Revolutions Medical Begins Manufacturing Selection Process for the Rev Vac Safety SyringeBusiness Wire(Tue, Sep 9)
REVOLUTIONS MEDICAL CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, Aug 21)
Revolutions Medical Finishes Filing Its International Patent Protection for the Rev Vac Safety SyringeBusiness Wire(Thu, Aug 21)
REVOLUTIONS MEDICAL CORP FinancialsEDGAR Online Financials(Thu, May 1)
REVOLUTIONS MEDICAL CORP Files SEC form 10KSB, Annual ReportEDGAR Online(Thu, Apr 24)
|Authorized ||Outstanding |
|Date ||Shares ||Source ||Date ||Shares ||Source |
|11/29/2006 ||250,000,000 ||DEF 14C ||07/28/2008 ||21,075,273 ||MGFS |
From Recent 10Q
As of the date of this report, we had a total of 10,292,500 options and warrants outstanding, which consisted of options to purchase up to 10,185,000 shares of common stock at exercise prices ranging from $0.08 to $10.00 per share(of which all were exercisable) and warrants to purchase up to 107,500 shares of common stock at an exercise price of $5.00 per share (all of which were exercisable). All of the options and warrants outstanding are presently "out of the money", meaning that the exercise price is greater than the current market price of our common stock. We may decide, however, to modify the terms and/or exercise price of these "out of the money" options and warrants. To the extent that the outstanding options and warrants to purchase our common stock are exercised, your ownership interest may be diluted. If the warrants and options are exercised and sold into the market, they could cause the market price of our common stock to decline.
As of June 30, 2008, the Company had 250,000,000 shares authorized and 20,717,388 shares outstanding. The authorized but unissued shares have the same rights and privileges as the common stock presently outstanding. The unissued authorized shares can be issued without further action of the shareholders. If and when, and to the extent that, the unissued authorized shares are issued and sold into the market, they could cause the market price of our common stock to decline.
Scott Key: 843-408-6265
2073 Shell Ring Circle
Mount Pleasant, SC 29466